These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9004880)

  • 1. [Intraocular rt-PA injection in fibrin formation after combined glaucoma and cataract operation].
    Steinkamp GW; Heider W; Schalnus R; Hattenbach LO
    Ophthalmologe; 1996 Oct; 93(5):558-60. PubMed ID: 9004880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
    Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
    J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
    Xie L; Li S; Dong X; Cao J; Shi W; Guo P
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):291-3. PubMed ID: 11877211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification-trabeculectomy surgery.
    Zarei R; Azimi R; Moghimi S; Abdollahi A; Amini H; Eslami Y; Fakhraii G
    J Cataract Refract Surg; 2006 Nov; 32(11):1921-5. PubMed ID: 17081897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.
    Koerner F; Boehnke M
    Ger J Ophthalmol; 1992; 1(5):354-60. PubMed ID: 1477641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tissue plasminogen activator to revive blebs following intraocular surgery.
    Smith MF; Doyle JW
    Arch Ophthalmol; 2001 Jun; 119(6):809-12. PubMed ID: 11405830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
    Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
    Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K; Greite JH; Bartenschlager EM
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
    Heiligenhaus A; Steinmetz B; Lapuente R; Krallmann P; Althaus C; Steinkamp WK; Dick B
    Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intraocular lens implantation on combined extracapsular cataract extraction with trabeculectomy: a comparative study.
    Neumann R; Zalish M; Oliver M
    Br J Ophthalmol; 1988 Oct; 72(10):741-5. PubMed ID: 3191074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.
    Yoshino H; Seki M; Ueda J; Yoshino T; Fukuchi T; Abe H
    BMC Ophthalmol; 2012 Mar; 12():3. PubMed ID: 22433746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator.
    Lesser GR; Osher RH; Whipple D; Abrams GW; Cionni RJ
    J Cataract Refract Surg; 1993 Mar; 19(2):301-5. PubMed ID: 8487179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)].
    Althaus C; Schelle C; Sundmacher R
    Klin Monbl Augenheilkd; 1996 Nov; 209(5):318-21. PubMed ID: 9044983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis of postcataract fibrin membranes in children.
    Mehta JS; Adams GG
    J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin.
    Toth CA; Nasir MA; Ho CL; Mittra RA
    Retina; 1997; 17(4):315-20. PubMed ID: 9279948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses.
    Tezel G; Kolker AE; Kass MA; Wax MB
    Ophthalmic Surg Lasers; 1997 Jul; 28(7):539-50. PubMed ID: 9243656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PMMA, foldable silicone and foldable acrylic hydrophobic intraocular lenses in combined phacoemulsification and trabeculectomy.
    Serpa Junior E; Wishart PK
    Arq Bras Oftalmol; 2005; 68(1):29-35. PubMed ID: 15824800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
    Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
    Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dense membrane formation after combined phacoemulsification-trabeculectomy surgery.
    Chan CC; Goldberg I
    Clin Exp Ophthalmol; 2005 Jun; 33(3):296-7. PubMed ID: 15932536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.